Cargando…
Repositioning of clinically approved drug Bazi Bushen capsule for treatment of Aizheimer's disease using network pharmacology approach and in vitro experimental validation
AIMS: To explore the new indications and key mechanism of Bazi Bushen capsule (BZBS) by network pharmacology and in vitro experiment. METHODS: The ingredients library of BZBS was constructed by retrieving multiple TCM databases. The potential target profiles of the components were predicted by targe...
Autores principales: | Wang, Tongxing, Chen, Meng, Li, Huixin, Ding, Guoyuan, Song, Yanfei, Hou, Bin, Yao, Bing, Wang, Zhixin, Hou, Yunlong, Liang, Junqing, Wei, Cong, Jia, Zhenhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336525/ https://www.ncbi.nlm.nih.gov/pubmed/37449101 http://dx.doi.org/10.1016/j.heliyon.2023.e17603 |
Ejemplares similares
-
Bazi Bushen capsule attenuates cognitive deficits by inhibiting microglia activation and cellular senescence
por: Ji, Chuanyuan, et al.
Publicado: (2022) -
Bazi Bushen Capsule Alleviates Post-Menopausal Atherosclerosis via GPER1-Dependent Anti-Inflammatory and Anti-Apoptotic Effects
por: Huang, Dan, et al.
Publicado: (2021) -
Corrigendum: Bazi Bushen Capsule Alleviates Post-Menopausal Atherosclerosis via GPER1-Dependent Anti-Inflammatory and Anti-Apoptotic Effects
por: Huang, Dan, et al.
Publicado: (2021) -
Bazi Bushen alleviates skin senescence by orchestrating skin homeostasis in SAMP6 mice
por: Xu, Zhe, et al.
Publicado: (2023) -
Qili Qiangxin (QLQX) capsule as a multi-functional traditional Chinese medicine in treating chronic heart failure (CHF): A review of ingredients, molecular, cellular, and pharmacological mechanisms
por: Wang, Tongxing, et al.
Publicado: (2023)